Masthead-Image-Right-min

The End of an Era: FDA is Rescinding Long-Contested LDT Rule for Labs

Withdrawal of LDT Rule Provides Regulatory Clarity and Reimbursement Guidance for Laboratories

Continue Reading...

From Red Flags to Readiness: How Labs Can Stay Ahead of Audit Risks

With $1.2B in improper lab payments projected, payers are ramping up audits—putting clinical labs under intense scrutiny.

Continue Reading...

What's Next for LDTs? A Look Beyond the Ruling

Get the key takeaways from our expert-led webinar on the LDT final rule ruling—and why labs must stay vigilant as the story unfolds.

Continue Reading...

Lab Compliance Strategies for Medical Necessity and Financial Health

Protect Your Lab: Key Strategies for Compliance and Medical Necessity Adherence.

Continue Reading...

FDA's New LDT Rule Unveiled: Key Insights and Lab Preparations

Prepare for compliance and explore alternatives to mitigate regulatory burdens amidst legislative and legal challenges.

Continue Reading...